(Q35566387)

English

Treatment with imatinib results in reduced IL-4-producing T cells, but increased CD4(+) T cells in the broncho-alveolar lavage of patients with systemic sclerosis

scientific article published on 5 September 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Treatment with imatinib results in reduced IL-4-producing T cells, but increased CD4(+) T cells in the broncho-alveolar lavage of patients with systemic sclerosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

1 reference

based on heuristic

inferred from title

author name string

Anagha A Divekar

1

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Dinesh Khanna

2

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Fereidoun Abtin

3

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Paul Maranian

4

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Rajeev Saggar

5

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Rajan Saggar

6

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Daniel E Furst

7

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Ram Raj Singh

8

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

publication date

5 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Clinical Immunology

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

141

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

293-303

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

A one-year, phase I/IIa, open-label pilot trial of imatinib mesylate in the treatment of systemic sclerosis-associated active interstitial lung disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221795

27 July 2018

Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221795

27 July 2018

A benefit-risk assessment of imatinib in chronic myeloid leukaemia and gastrointestinal stromal tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221795

27 July 2018

Molecular framework for response to imatinib mesylate in systemic sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221795

27 July 2018

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221795

27 July 2018

Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221795

27 July 2018

Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221795

27 July 2018

High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221795

27 July 2018

Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221795

27 July 2018

Cyclophosphamide versus placebo in scleroderma lung disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221795

27 July 2018

Alterations of mononuclear inflammatory cells, CD4/CD8+ T cells, interleukin 1beta, and tumour necrosis factor alpha in the bronchoalveolar lavage fluid, peripheral blood, and skin of patients with systemic sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221795

27 July 2018

Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221795

27 July 2018

GOstat: find statistically overrepresented Gene Ontologies within a group of genes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221795

27 July 2018

Eosinophils and T lymphocytes possess distinct roles in bleomycin-induced lung injury and fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221795

27 July 2018

Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221795

27 July 2018

Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221795

27 July 2018

Small airways in progressive systemic sclerosis (PSS)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221795

27 July 2018

Bronchoalveoloar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221795

26 September 2018

Altered adhesion molecules expression on peripheral blood mononuclear cells from patients with systemic sclerosis and clinical correlations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221795

26 September 2018

Significant improvement of right ventricular function by imatinib mesylate in scleroderma-associated pulmonary arterial hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221795

26 September 2018

Efficacy of imatinib mesylate in the treatment of refractory sclerodermatous chronic GVHD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221795

26 September 2018

Imatinib mesylate treatment of nephrogenic systemic fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221795

26 September 2018

T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221795

26 September 2018

Interstitial lung disease in systemic sclerosis: a simple staging system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221795

26 September 2018

Imatinib for the treatment of refractory, diffuse systemic sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221795

26 September 2018

The effect of imatinib (Glivec) on scleroderma and normal dermal fibroblasts: a preclinical study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221795

26 September 2018

Visfatin, an adipocytokine with proinflammatory and immunomodulating properties.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221795

26 September 2018

Imatinib mesylate suppresses cytokine synthesis by activated CD4 T cells of patients with chronic myelogenous leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221795

26 September 2018

Inhibition of c-fms by imatinib: expanding the spectrum of treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221795

26 September 2018

Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent manner

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221795

26 September 2018

G-CSF as immune regulator in T cells expressing the G-CSF receptor: implications for transplantation and autoimmune diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221795

26 September 2018

Dual roles of IL-4 in lung injury and fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221795

26 September 2018

Clinical significance of soluble CD31 in patients with systemic sclerosis (SSc): association with limited cutaneous SSc.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221795

26 September 2018

Importance of ground-glass attenuation in chronic diffuse infiltrative lung disease: pathologic-CT correlation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221795

26 September 2018

Stem cell mobilization with G-CSF induces type 17 differentiation and promotes scleroderma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221795

7 December 2018

Histopathologic variability in usual and nonspecific interstitial pneumonias

1 reference

https://pubmed.ncbi.nlm.nih.gov/22015344

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alveolar macrophages from systemic sclerosis patients: evidence for IL-4-mediated phenotype changes

1 reference

https://pubmed.ncbi.nlm.nih.gov/22015344

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pulmonary function in scleroderma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22015344

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of interlobar variation of bronchoalveolar lavage cellular differentials in interstitial lung diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/22015344

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica

1 reference

https://pubmed.ncbi.nlm.nih.gov/22015344

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Idiopathic pulmonary fibrosis: predicting response to therapy and survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/22015344

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22015344

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myofibroblast induction and microvascular alteration in scleroderma lung fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22015344

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intracellular Th1/Th2 balance of pulmonary CD4(+) T cells in patients with active interstitial pneumonia evaluated by serum KL-6

1 reference

https://pubmed.ncbi.nlm.nih.gov/22015344

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.CLIM.2011.08.010

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35566387&oldid=1584532852"